EP 2240194 A1 20101020 - TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR
Title (en)
TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR
Title (de)
MELANOMBEHANDLUNG MIT ALPHA-THYMOSIN-PEPTIDEN IN KOMBINATION MIT EINEM KINASE-INHIBITOR
Title (fr)
TRAITEMENT DE MÉLANOME PAR DES PEPTIDES D'ALPHA THYMOSINE EN ASSOCIATION AVEC UN INHIBITEUR DE KINASE
Publication
Application
Priority
- US 2008086545 W 20081212
- US 1347607 P 20071213
Abstract (en)
[origin: WO2009076587A1] Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administering a melanoma-treating combination to a human melanoma patient during a treatment regimen, the combination including an alpha thymosin peptide and a kinase inhibitor.
IPC 8 full level
A61K 38/00 (2006.01); A61K 31/4164 (2006.01); A61K 31/4412 (2006.01); A61K 38/22 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/4164 (2013.01 - EP US); A61K 38/2292 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009076587 A1 20090618; AR 069769 A1 20100217; AU 2008335025 A1 20090618; CA 2708229 A1 20090618; CN 101945664 A 20110112; EP 2240194 A1 20101020; EP 2240194 A4 20111221; JP 2011506473 A 20110303; US 2010267637 A1 20101021
DOCDB simple family (application)
US 2008086545 W 20081212; AR P080105451 A 20081215; AU 2008335025 A 20081212; CA 2708229 A 20081212; CN 200880126813 A 20081212; EP 08858909 A 20081212; JP 2010538181 A 20081212; US 74743808 A 20081212